220 related articles for article (PubMed ID: 26395067)
1. Increased precision of orthotopic and metastatic breast cancer surgery guided by matrix metalloproteinase-activatable near-infrared fluorescence probes.
Chi C; Zhang Q; Mao Y; Kou D; Qiu J; Ye J; Wang J; Wang Z; Du Y; Tian J
Sci Rep; 2015 Sep; 5():14197. PubMed ID: 26395067
[TBL] [Abstract][Full Text] [Related]
2. Fluorescence Molecular Imaging and Tomography of Matrix Metalloproteinase-Activatable Near-Infrared Fluorescence Probe and Image-Guided Orthotopic Glioma Resection.
Li L; Du Y; Chen X; Tian J
Mol Imaging Biol; 2018 Dec; 20(6):930-939. PubMed ID: 29651576
[TBL] [Abstract][Full Text] [Related]
3. In vivo breast cancer characterization imaging using two monoclonal antibodies activatably labeled with near infrared fluorophores.
Sano K; Mitsunaga M; Nakajima T; Choyke PL; Kobayashi H
Breast Cancer Res; 2012; 14(2):R61. PubMed ID: 22510481
[TBL] [Abstract][Full Text] [Related]
4. Image-guided surgery using near-infrared Turn-ON fluorescent nanoprobes for precise detection of tumor margins.
Blau R; Epshtein Y; Pisarevsky E; Tiram G; Israeli Dangoor S; Yeini E; Krivitsky A; Eldar-Boock A; Ben-Shushan D; Gibori H; Scomparin A; Green O; Ben-Nun Y; Merquiol E; Doron H; Blum G; Erez N; Grossman R; Ram Z; Shabat D; Satchi-Fainaro R
Theranostics; 2018; 8(13):3437-3460. PubMed ID: 30026858
[TBL] [Abstract][Full Text] [Related]
5. Fibronectin-targeting and metalloproteinase-activatable smart imaging probe for fluorescence imaging and image-guided surgery of breast cancer.
Cheng Z; Jin Y; Li J; Shi G; Yu L; Shao B; Tian J; Du Y; Yuan Z
J Nanobiotechnology; 2023 Mar; 21(1):112. PubMed ID: 36978072
[TBL] [Abstract][Full Text] [Related]
6. AND-gate contrast agents for enhanced fluorescence-guided surgery.
Widen JC; Tholen M; Yim JJ; Antaris A; Casey KM; Rogalla S; Klaassen A; Sorger J; Bogyo M
Nat Biomed Eng; 2021 Mar; 5(3):264-277. PubMed ID: 32989286
[TBL] [Abstract][Full Text] [Related]
7. Effect of Dye and Conjugation Chemistry on the Biodistribution Profile of Near-Infrared-Labeled Nanobodies as Tracers for Image-Guided Surgery.
Debie P; Van Quathem J; Hansen I; Bala G; Massa S; Devoogdt N; Xavier C; Hernot S
Mol Pharm; 2017 Apr; 14(4):1145-1153. PubMed ID: 28245129
[TBL] [Abstract][Full Text] [Related]
8. Dual-labeled trastuzumab-based imaging agent for the detection of human epidermal growth factor receptor 2 overexpression in breast cancer.
Sampath L; Kwon S; Ke S; Wang W; Schiff R; Mawad ME; Sevick-Muraca EM
J Nucl Med; 2007 Sep; 48(9):1501-10. PubMed ID: 17785729
[TBL] [Abstract][Full Text] [Related]
9. Preclinical evaluation of near-infrared (NIR) fluorescently labeled cetuximab as a potential tool for fluorescence-guided surgery.
Saccomano M; Dullin C; Alves F; Napp J
Int J Cancer; 2016 Nov; 139(10):2277-89. PubMed ID: 27428782
[TBL] [Abstract][Full Text] [Related]
10. Fluorescence-guided resection of experimental malignant glioma using cetuximab-IRDye 800CW.
Warram JM; de Boer E; Korb M; Hartman Y; Kovar J; Markert JM; Gillespie GY; Rosenthal EL
Br J Neurosurg; 2015; 29(6):850-8. PubMed ID: 26073144
[TBL] [Abstract][Full Text] [Related]
11. Precise integrin-targeting near-infrared imaging-guided surgical method increases surgical qualification of peritoneal carcinomatosis from gastric cancer in mice.
Cheng H; Chi C; Shang W; Rengaowa S; Cui J; Ye J; Jiang S; Mao Y; Zeng C; Huo H; Chen L; Tian J
Oncotarget; 2017 Jan; 8(4):6258-6272. PubMed ID: 28009982
[TBL] [Abstract][Full Text] [Related]
12. Optical See-Through Cancer Vision Goggles Enable Direct Patient Visualization and Real-Time Fluorescence-Guided Oncologic Surgery.
Mondal SB; Gao S; Zhu N; Habimana-Griffin L; Akers WJ; Liang R; Gruev V; Margenthaler J; Achilefu S
Ann Surg Oncol; 2017 Jul; 24(7):1897-1903. PubMed ID: 28213790
[TBL] [Abstract][Full Text] [Related]
13. Intraoperative near-infrared fluorescence tumor imaging with vascular endothelial growth factor and human epidermal growth factor receptor 2 targeting antibodies.
Terwisscha van Scheltinga AG; van Dam GM; Nagengast WB; Ntziachristos V; Hollema H; Herek JL; Schröder CP; Kosterink JG; Lub-de Hoog MN; de Vries EG
J Nucl Med; 2011 Nov; 52(11):1778-85. PubMed ID: 21990576
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of a novel ovarian cancer-specific fluorescent antibody probe for targeted near-infrared fluorescence imaging.
Chen J; Zhang C; Guo Y; Chang X; Ma R; Ye X; Cheng H; Li Y; Cui H
World J Surg Oncol; 2020 Apr; 18(1):66. PubMed ID: 32252772
[TBL] [Abstract][Full Text] [Related]
15. EpCAM as multi-tumour target for near-infrared fluorescence guided surgery.
van Driel PB; Boonstra MC; Prevoo HA; van de Giessen M; Snoeks TJ; Tummers QR; Keereweer S; Cordfunke RA; Fish A; van Eendenburg JD; Lelieveldt BP; Dijkstra J; van de Velde CJ; Kuppen PJ; Vahrmeijer AL; Löwik CW; Sier CF
BMC Cancer; 2016 Nov; 16(1):884. PubMed ID: 27842504
[TBL] [Abstract][Full Text] [Related]
16. A Tumor-Activatable Theranostic Nanomedicine Platform for NIR Fluorescence-Guided Surgery and Combinatorial Phototherapy.
Li X; Schumann C; Albarqi HA; Lee CJ; Alani AWG; Bracha S; Milovancev M; Taratula O; Taratula O
Theranostics; 2018; 8(3):767-784. PubMed ID: 29344305
[TBL] [Abstract][Full Text] [Related]
17. Improved resection and prolonged overall survival with PD-1-IRDye800CW fluorescence probe-guided surgery and PD-1 adjuvant immunotherapy in 4T1 mouse model.
Du Y; Sun T; Liang X; Li Y; Jin Z; Xue H; Wan Y; Tian J
Int J Nanomedicine; 2017; 12():8337-8351. PubMed ID: 29200846
[TBL] [Abstract][Full Text] [Related]
18. Photoacoustic and fluorescence image-guided surgery using a multifunctional targeted nanoprobe.
Xi L; Zhou G; Gao N; Yang L; Gonzalo DA; Hughes SJ; Jiang H
Ann Surg Oncol; 2014 May; 21(5):1602-9. PubMed ID: 24554061
[TBL] [Abstract][Full Text] [Related]
19. Design strategy for a near-infrared fluorescence probe for matrix metalloproteinase utilizing highly cell permeable boron dipyrromethene.
Myochin T; Hanaoka K; Komatsu T; Terai T; Nagano T
J Am Chem Soc; 2012 Aug; 134(33):13730-7. PubMed ID: 22830429
[TBL] [Abstract][Full Text] [Related]
20. Intraoperative Tumor Detection Using a Ratiometric Activatable Fluorescent Peptide: A First-in-Human Phase 1 Study.
Unkart JT; Chen SL; Wapnir IL; González JE; Harootunian A; Wallace AM
Ann Surg Oncol; 2017 Oct; 24(11):3167-3173. PubMed ID: 28699134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
